Results 171 to 180 of about 79,234 (256)

Glasgow prognostic score as a predictor of adjuvant nivolumab efficacy in esophageal squamous cell carcinoma. [PDF]

BMC Gastroenterol
Kara M, Ebinç S, Sezgin Y, Ürün M, Aldemir MN.   +4 more
europepmc   +1 more source

What Is Your Diagnosis? Fine‐Needle Aspirate From a Lingual Mass in a Cat

Veterinary Clinical Pathology, EarlyView.
Emma Stacey, Andrii Trokoz, Kimberly Williams, Dorothee Bienzle   +3 more
wiley   +1 more source

Intratumoral Microbiota in Tumor: Current Understandings and Future Perspectives

MedComm, Volume 7, Issue 7, July 2026.
Intratumoral bacteria are emerging as active regulators of cancer evolution rather than bystanders. This review outlines how tumor‐resident microbes drive tumor initiation and growth by inducing genomic instability, epigenetic reprogramming, oncogenic signaling, and chronic inflammation, while promoting metastatic spread via invasion, angiogenesis ...
Jiawei Chen, Yupan Bai, Lu Shen, Jiacheng Ying, Jie Xu, Jiayin Tang, Yujie Bao   +6 more
wiley   +1 more source

PRDM1: a useful indicator of differentiation and prognosis in esophageal squamous cell carcinoma. [PDF]

Diagn Pathol
Huang A, Jiang X, Qi Y, Chen J, Guo X, Lu J, Jin M.   +6 more
europepmc   +1 more source

Molecular Interplay of PARN and Telomerase: Tail Modifiers and Disease Implications

WIREs RNA, Volume 17, Issue 4, July/August 2026.
Schematic representation of the molecular interplay between PARN, telomerase‐associated, and the involvement of p53 in regulating telomere maintenance and genome stability. The top panel shows how normal PARN levels are involved in regulating p53 levels and balanced telomerase activity through their regulatory interaction with TERC and TERRA, thus ...
Sujitha Felicitus, Shalon Suzanne Pinto, Sai Samanvitha Madagundapalli Ramakrishna, Dechamma Pandyanada Nanjappa, Gunimala Chakraborty, Anirban Chakraborty   +5 more
wiley   +1 more source

Model‐Informed Development of a Subcutaneous Formulation of Tislelizumab: Phase 1 Pharmacokinetics in Patients With Cancer

Clinical and Translational Science, Volume 19, Issue 7, July 2026.
ABSTRACT Although tislelizumab is approved across multiple malignancies and dosing schedules, intravenous administration imposes logistical burdens. A subcutaneous formulation may improve convenience and reduce resource demands if comparable exposure is achieved. This study evaluated the pharmacokinetics, bioavailability, and injection‐site performance
Xiangyu Liu, Ye Guan, Yixi Liu, Tian Yu, Ramil Abdrashitov, Ziru Niu, Xiao Lin, Xiaohan Ye, Yutong Wang, Srikumar Sahasranaman, William D. Hanley, Nageshwar Budha   +11 more
wiley   +1 more source

ZNF750 suppresses esophageal squamous cell carcinoma by maintaining epithelial barrier-driven mucosal immune homeostasis. [PDF]

Biol Direct
Zhou T, Fan J, Wang M, Cheng C, Yuan F, Li J, Wan H, Cui D, Miao Y, Bi Y.   +9 more
europepmc   +1 more source

Ultrasonographic and Endoscopic Findings of Pancreatic Adenocarcinoma With Duodenal Invasion in a Brown Bear (Ursus arctos)

Veterinary Radiology &Ultrasound, Volume 67, Issue 4, July 2026.
ABSTRACT This report describes a 25‐year‐old, intact male brown bear (Ursus arctos) presenting with weight loss, diarrhea, melena, apathy, and a 12% hematocrit. Ultrasound showed proximal duodenal wall thickening with submucosal cysts and a large, heterogeneous, highly vascularized mass in the descending duodenum, containing small gas pockets and ...
Mariana Giendruczak de Souza, Arthur Carlos da Trindade Alves, Bernardo de Paula Miranda, Felipe Kataoka, Bruna Patrícia Siqueira Raimundo, Daniela Oliveira Rocha, Daniel Guimarães Ubiali, Gabriela Castro Lopes Evangelista, Marcus Antônio Rossi Feliciano   +8 more
wiley   +1 more source

Revisiting Thoracic Duct Resection in Esophageal Squamous Cell Carcinoma: A Propensity-Matched Analysis and Immunologic Insight Into Recurrence Risk. [PDF]

Thorac Cancer
Zhang X, Liu XY, Lv YJ, Li SN, Ao Y, Zhong LQ, Hu Y.   +6 more
europepmc   +1 more source